Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11639393 Anti-CCR8 antibodies
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
July 27, 2022
0
Date of Patent
May 2, 2023
0
Patent Applicant
AbbVie Inc.
0
Patent Application Number
17815505
0
Patent Citations
US Patent 10087259 Depleting tumor-specific tregs
0
US Patent 10550191 Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8
0
Patent Inventor Names
Julie L. Wilsbacher
0
Jane Seagal
0
Andrew J. McCluskey
0
Amanda M. Schmidt Paustian
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11639393
0
Patent Primary Examiner
Aurora M Fontainhas
0
CPC Code
C12N 15/85
0
C07K 2317/41
0
C07K 16/2866
0
C07K 2317/52
0
A61P 35/00
0
Find more entities like US Patent 11639393 Anti-CCR8 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE